SelectION

About:

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

Website: http://selectiontherapeutics.com

Top Investors: Global Source Ventures, SDL Ventures

Description:

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases and selecting cancer indications by targeting autoreactive, chronically activated T cells. It has established a technology platform to develop potent and highly selective peptide blockers for ion channels involved in various diseases. Its platform enables to optimize the target selectivity, providing the opportunity to develop drugs with significantly improved efficacy and safety profiles.